The extracellular matrix of gliomas: Modulation of cell function

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 10, 1999, Pages 1029-1040

  Gladson, Candece L ^a  

^a Biomedical Research Building II   (United States)

Author keywords

Astrocytoma; Extracellular Matrix; Glioblastoma; Glioma; Integrins; Invasion

Indexed keywords

INTEGRIN RECEPTOR; LIGAND; OSTEOPONTIN; PROTEOGLYCAN; SCLEROPROTEIN; TENASCIN;

BLOOD VESSEL; CANCER INVASION; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GLIOMA; HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; TUMOR CELL;

EID: 0032850844     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199910000-00001     Document Type: Review

References (95)

1. Bonner-Fraser M, Stern CD, Fraser S. Analysis of neural crest cell lineage and migration. J Carniofacial Genet Dev Biol 1991;1: 214-22
2. Crossin KL. Tenascin: A multifunctional extracellular matrix protein with a restricted distribution in development and disease. J Cell Biochem 1996;61:592-98
3. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25
4. Sage EH. Terms of attachment: Sparc and tumorigenesis. Nat Med 1997;3:144-46
5. Clark EA, Brugge JS. Integrins and signal transduction pathways: The road taken. Science 1995;268:233-39
6. Asher R, Perides G, Vanderhaeghen JJ, Birnami A. Extracellular matrix of central nervous system white matter: Demonstration of an hyaluronate-protein complex. J Neurosci Res 1991;28:410-21
7. Delpech B, Delpech A, Bruckner G, Girard N, Maingonnat C. Hyaluronan and haluronectin in the nervous system. In: Evered D, Whelen J, ed. The biology of hyaluronan. Chichester: John Wiley & Sons, 1989;208-32
8. Lebaron RG. Versican. Perspect Dev Neurobiol 1996;3:261-71
9. Margolis RU, Margolis RK. Nervous tissue proteoglycans. Dev Neurosci 1989;11:276-88
10. Margolis RU, Margolis RK. Aggrecan-versican-neurocan family proteoglycans. Methods Enzymol 1994;245:105-26
11. Rutka JT, Apodaca G, Stern R, Rosenblum M. The extracellular matrix of the central and peripheral nervous systems: Structure and function. J Neurosurg 1988;69:155-70
12. Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 1983;43:2796-803
13. Gladson CL, Cheresh DA. Glioblastoma expression of vitronectin and the avβ3 integrin: Adhesion mechanism for transformed glial cells. J Clin Invest 1991;88:1924-32
14. Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci 1995;108:947-56
15. Rempel SA, Golembieski WA, Ge S, Lemke N, Elisevich K, Mikkelsen T, Guttierrez JA. SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropath Exp Neurol 1998;57:1112-21
16. Jaworski DM, Kelly GM, Hockfield S. BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to the brain. J Cell Biol 1994;125:495-509
17. Rutka JT. The K.G. McKenzie award lecture - 1986. Effects of extracellular matrix proteins on the growth and differentiation of an anaplastic glioma cell line. Can J Neurol Sci 1986;13:301-6
18. Kleihues P, Burker PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol 1993;3:255-68
19. th ed. Baltimore: Williams & Wilkins, 1989:73-289
20. Bellon G, Caulet T, Cam Y, Pluot M, Poulin G, Pvtlinska M, Bernard MH. Immunohistochemical localisation of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas. Acta Neuropathol 1985;66:245-52
21. Jones TR, Ruoslahti E, Schold SC, Bigner DD. Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas. Cancer Res 1982;42:168-77
22. McComb RD, Bigner DD. Immunolocalization antibody-defined extracellular matrix antigens in human brain tumors. J Neuro-Oncol 1985;3:181-86
23. McComb RD, Bigner DD. Immunolocalization of laminin in neoplasms of the central and peripheral nervous system. J Neuropathol Exp Neurol 1985;44:242-53
24. McComb RD, Moul JM, Bigner DD. Distribution of type VI collagen in human gliomas: Comparison with fibronectin and gliomamesenchymal matrix glycoprotein. J Neuropathol Exp Neurol 1987;46:623-33
25. Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 1993;85:481-87
26. Zagzag D, Friedlander DR, Dosik J, et al. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 1996;56:182-89
27. Zagzag D, Friedlander DR, Miller DC, et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 1995;55: 907-14
28. Hsu SC, Volpert OV, Steck PA, et al. Inhibition of angiogenesis in human glioblastomas by chromosone 10 induction of thrombospondin-1. Cancer Res 1996;56:5684-91
29. Pijuan-Thompson V, Grammer JR, Stewart J, et al. Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. Exp Cell Res 1999;249: 86-101
30. Bigner DD, Brown MT, Friedman AH, et al. Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Onc 1998;16:2202-12
31. Roberts DD. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 1996;10:1183-91
32. Gao A-G, Lindbert FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 1996;271;21-24
33. Bradshaw AD, Francki A, Motamed K, Howe C, Sage EH. Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol Biol Cell 1999;10: 1569-79
34. Schrappe M, Klier FG, Spiro RC, Waltz TA, Reisfeld RA, Gladson CL. Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. Cancer Res 1991;51:4986-93
35. Paulus W, Baur I, Dours-Zimmermann MT, Zimmermann DR. Differential expression of versican isoforms in brain tumors. J Neuropathol Exp Neurol 1996;55:528-33
36. Burg MA, Nishiyama A, Stallcup WB. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp Cell Res 1997;235:254-64
37. Nishiyama A, Dahlin KJ, Prince JT, Johnstone SR, Stallcup WB. The primary structure of NG2, a novel membrane-spanning proteoglycan. J Cell Biol 1991;114:359-71
38. Bumol TF, Reisfeld RA. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc. Natl. Acad. Sci. USA 1982;79:1245-49
39. Nishiyama A, Lin XH, Stallcup WB. Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis. Mol Biol Cell 1995;6:1819-32
40. Saitoh Y, Kuratsu J-I, Takeshima H, Yamamoto S, Ushio Y. Expression of osteopontin in human glioma: Its correlation with the malignancy. Lab Invest 1995;72:55-63
41. Tomasini BR, Mosher DF. Vitronectin. In: Coller BS, ed. Progress in haemostasis and thrombosis. Vol. 10. Philadelphia: W.B. Saunders Company, Harcourt Brace Javanovich, Inc., 269-306
42. Seiffert D, Keeton M, Eguchi Y, Sawdey M, Loskutoff DJ. Detection of vitronectin mRNA in tissues and cells of the mouse. Proc Natl Acad Sci USA 1991;88:9402-6
43. Denhardt DT, Guo X. Osteopontin: A protein with diverse functions. FASEB J 1993;7:1475-82
44. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 1994;54:832-37
45. Golembieski WA, Ge S, Nelson K, Mikkelsen T, Rempel SA. Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int J Dev Neurosci 1999(in press)
46. Giese A, Kluwe L, Laube B, Meissner H, Berens ME, Westphal M. Migration of human glioma cells on myelin. Neurosurgery 1996;38:755-64
47. Berens ME, Rief MD, Loo MA, Giese A. The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin Exp Metastasis 1994;12:405-15
48. Giese A, Rief MD, Loo MA, Berens MA. Determinants of human astrocytoma migration. Cancer Research 1994;54:3897-904
49. Haugland HK, Tysnes BB, Tysnes O-B. Adhesion and migration of human glioma cells are differently dependent on extracellular matrix molecules. Anticancer Research 1997;17:1035-43
50. 1 integrins. Cancer Res 1996;56:1939-47
51. LeMosy EK, Lightner VA, Erickson HP. Structural analysis of a human glial variant laminin. Exp Cell Res 1996;227:80-88
52. Bertolotto A, Goia L, Schiffer D. Immunohistochemical study of chondroitin sulfate in human gliomas. Acta Neuropathol 1986;72: 189-96
53. Bertolotto A, Magrassi ML, Orsi L, Sitla C, Schiffer D. Glycosaminoglycan changes in human gliomas. J Neuro-Oncology 1986;4: 43-48
54. Jaworski DM, Kelly GM, Piepmeier JM, Hockfield S. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Res 1996;56:2293-98
55. Asher R, Bignami A. Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 1992;203: 80-90
56. Borland G, Ross JA, Guy K. Forms and functions of CD44. Immunology 1998;93:139-48
57. Steck PA, Moser RP, Bruner JM, et al. Altered expression and distribution of heparan sulfate proteoglycans in human gliomas. Cancer Res 1989;49:2096-103
58. Maleski M, Hockfield S. Glial cells assemble hyaluronan-based pericellular matrices in vitro. Glia 1997;20:193-202
59. Koochekpour S, Pilkington GJ, Merzak A. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer 1995;63:450-54
60. Zhang H, Kelly G, Zerillo C, Jaworski DM, Hockfield S. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in vivo. J Neurosci 1998;18:2370-76
61. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995;121:2303-12
62. Grumet M, Flaccus A, Margolis RU. Functional characterization of chondroitin sulfate proteoglycans of brain: Interactions with neurons and neural cell adhesion molecules. J Cell Biol 1993;120:815-24
63. Grumet M, Milev P, Sakurai T, et al. Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. J Biol Chem 1994;269:12142-46
64. Rauch U, Gao P, Janetzko A, et al. Isolation and characterization of developmentally regulated chondroitin sulfate and chondroitin/ keratan sulfate proteoglycans of brain identified with monoclonal antibodies. J Biol Chem 1991;266:14785-801
65. Sakurai T, Friedlander DR, Grumet M. Expression of polypeptide variants of receptor-type protein tyrosine phosphatase beta: The secreted form, phosphacan, increases dramatically during embryonic development and modulates glial cell behavior in vitro. J Neurosci Res 1996;43:694-706
66. Preobrazhensky AA, Oohira A, Maier G, Voronina AS, Vovk TS, Barabanov VM. Identification of monoclonal antibody At5 as a new member of NHK-1 antibody family: The reactivity with myelin-associated glycoprotein and with two brain-specific proteoglycans, phosphacan and neurocan. Neurochem Res 1997;22:133-40
67. Paulus W, Baur I, Schuppan D, Roggendorf W. Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 1993;143:154-63
68. Gingras M-C, Roussel E, Bruner JM, Branch CD, Moser RP. Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunology 1995;57:143-53
69. Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest 1995;95:713-24
70. Bourdon MA, Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 1989;108:1149-55
71. Deryugina EI, Bourdon MA. Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Science 1996;109:643-52
72. Giese A, Loo MA, Norman SA, Treasurywala S, Berens ME. Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J Cell Sci 1996;109:2161-68
73. Pijuan-Thompson V, Gladson CL. Ligation of integrin α5β1 is required for internalization of vitronectin by integrin αvβ3. J Biol Chem 1997;272:2736-43
74. Rutka JT, Muller M, Hubbard SL, et al. Astrocytoma adhesion to extracellular matrix: Functional significance of integrin and focal adhesion kinase expression. J Neuropathol Exp Neurol 1999;58: 198-209
75. Mohanam S, Gladson CL, Rao CN, Rao JS. Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors. Frontiers in Biosci 1999;4:178-87
76. Hayashi K, Madri JA, Yurchenco PD. Endothelial cells interact with the core protein of basement membrane perlecan through β1 and β3 integrins: an adhesion modulated by glycosaminoglycans. J Cell Biol 1992;119:945-59
77. Katagiri UY, Sleeman J, Fujii H, et al. CD44 variants but not CD44s cooperate with β1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 1999;59:219-26
78. Lindberg FP, Gresham HD, Schwarz E, Brown EJ. Molecular cloning of integrin-associated protein: An immunoglobulin family member with multiple membrane-spanning domains implicated in αvβ3-dependent ligand binding. J Cell Biol 1993;123:485-96
79. Chintala SK, Mohanan S, Go Y, et al. Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor. Mol Carcinog 1997;20:355-65
80. Merzak A, Koocheckpour S, Pilkington GJ. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 1994;54: 3988-92
81. Chintala SK, Gokaslan ZL, Go Y, Sawaya R, Nicolson GL, Rao JS. Role of extracellular matrix proteins in regulation of human glioma invasion. Clin Exp Metastasis 1996;14:358-66
82. Baltuch GH, de Tribolet N, Van Meir EG. Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system. J Neuro-Oncology 1995;26:191-98
83. Kaaijk P, Troost D, Morsink F. et al. Expression of CD44 splice variants in human primary brain tumors. J Neuro-Oncology 1995;26:185-90
84. Kuppner MC, Van Meir EG, Gauthier T, Hamou M-F, de Tribolet N. Differential expression of the CD44 molecule in human brain tumors. Int J Cancer 1992;50:572-77
85. Okada H, Yoshida J, Sokabe M, Wakabayashi T, Hagiwara M. Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int J Cancer 1996;66:255-60
86. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;271:509-12
87. Radotra B, McCormick D. Glioma invasion in vitro is mediated by CD44-hyaluronan interactions. J Pathol 1997;181:434-38
88. Chung CY, Murphy-Ullrich JE, Erickson HP. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 1996;7:883-92
89. Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL. Vitronectin, a glioma derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin Cancer Res 1999;5:1587-94
90. Liang Y, Haring M, Roughley PJ, Margolis RK, Margolis RU. Glypican and biglycan in the nuclei of neurons and glioma cells: Presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J Cell Biol 1997;139: 851-64
91. Toker A, Cantley LC. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997;387:673-76
92. Ling J, Liu Z, Wang D, Gladson CL. Malignant astrocytoma cell attachment and migration to various matrix proteins is differentially sensitive to phosphoinositide 3-OH kinase inhibitors. J Cell Biochem 1999;73:533-44
93. Cary LA, Chang JF, Guan J-L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 1996;109:1787-94
94. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol 1998;140:961-72
95. Paulus W, Baur I, Beutler AS, Reeves SA. Diffuse brain invasion of glioma cells requires β1 integrins. Lab Invest 1996;75:819-26